Abb Ltd
SIX:ABBN

Watchlist Manager
Abb Ltd Logo
Abb Ltd
SIX:ABBN
Watchlist
Price: 58.32 CHF 2.28% Market Closed
Market Cap: 107.5B CHF

Intrinsic Value

The intrinsic value of one ABBN stock under the Base Case scenario is 41.19 CHF. Compared to the current market price of 58.32 CHF, Abb Ltd is Overvalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABBN Intrinsic Value
41.19 CHF
Overvaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Abb Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about ABBN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ABBN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Abb Ltd.

Explain Valuation
Compare ABBN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ABBN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Abb Ltd

Current Assets 22.4B
Cash & Short-Term Investments 6B
Receivables 9.2B
Other Current Assets 7.2B
Non-Current Assets 21.3B
Long-Term Investments 437m
PP&E 5.5B
Intangibles 12.5B
Other Non-Current Assets 2.8B
Current Liabilities 16B
Accounts Payable 5.3B
Accrued Liabilities 270m
Short-Term Debt 40m
Other Current Liabilities 10.5B
Non-Current Liabilities 12.6B
Long-Term Debt 7.8B
Other Non-Current Liabilities 4.8B
Efficiency

Free Cash Flow Analysis
Abb Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Abb Ltd

Revenue
34.5B USD
Cost of Revenue
-20.8B USD
Gross Profit
13.7B USD
Operating Expenses
-7.7B USD
Operating Income
6B USD
Other Expenses
-1.6B USD
Net Income
4.4B USD
Fundamental Scores

ABBN Profitability Score
Profitability Due Diligence

Abb Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
Healthy Gross Margin
Positive 3Y Average ROIC
58/100
Profitability
Score

Abb Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

ABBN Solvency Score
Solvency Due Diligence

Abb Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
74/100
Solvency
Score

Abb Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABBN Price Targets Summary
Abb Ltd

Wall Street analysts forecast ABBN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBN is 57.12 CHF with a low forecast of 43.43 CHF and a high forecast of 71.4 CHF.

Lowest
Price Target
43.43 CHF
26% Downside
Average
Price Target
57.12 CHF
2% Downside
Highest
Price Target
71.4 CHF
22% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ABBN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

ABBN News

Other Videos
What is the Intrinsic Value of one ABBN stock?

The intrinsic value of one ABBN stock under the Base Case scenario is 41.19 CHF.

Is ABBN stock undervalued or overvalued?

Compared to the current market price of 58.32 CHF, Abb Ltd is Overvalued by 29%.

Back to Top